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Abstract
Background: Intrauterine fetal death (IUFD) is a tragic event and, despite efforts to reduce rates, its incidence
remains difficult to reduce. The objective of the present study was to examine the etiological factors that contribute
to the main causes and conditions associated with IUFD, over an 11-year period in a region of North-East Italy
(Friuli Venezia Giulia) for which reliable data in available.
Methods: Retrospective analysis of all 278 IUFD cases occurred between 2005 and 2015 in pregnancies with
gestational age ≥ 23 weeks.
Results: The incidence of IUFD was 2.8‰ live births. Of these, 30% were small for gestational age (SGA), with
immigrant women being significantly over-represented. The share of SGA reached 35% in cases in which a
maternal of fetal pathological condition was present, and dropped to 28% in the absence of associated pathology.
In 78 pregnancies (28%) no pathology was recorded that could justify IUFD. Of all IUFDs, 11% occurred during
labor, and 72% occurred at a gestational age above 30 weeks.
Conclusion: The percentage of IUFD cases for which no possible cause can be identified is quite high. Only the
adoption of evidence-based diagnostic protocols, with integrated immunologic, genetic and pathologic examinations,
can help reduce this diagnostic gap, contributing to the prevention of future IUFDs.
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Background
The intrauterine fetal demise is, for a woman and for a
couple, always an enormous psycho-affective trauma [1].
The search for the cause is not only a due act, but is
fundamental to improve care by acting on prevention
measures.
Fetal death still presents several aspects that have not
been ascertained and on which agreement has not been
reached. Among these, is the definition of the reference
population, in terms of gestational age at the event and
fetal weight category [2–7].
In Italy, for many years, the cut-off date that distin-
guished abortion from fetal death was set at 180 days
(25 weeks and 5 days), arbitrarily interpreting Law No.
194/78, which identified this gestational age as the upper
limit for voluntary interruption of pregnancy according
to Article 6 [8]. This period was considered, at the time
of the promulgation of the Law in 1978, the boundary
between impossibility and possibility of neonatal sur-
vival. Medical evolution has, however, lowered this limit,
in some cases permitting neonatal survivals at 23 weeks
of gestation. For this reason, the ≥23 weeks limit is fre-
quently employed for the definition of IUFD in the ma-
jority of Italian studies [9–11].
This heterogeneity in the definition of fetal death or
“stillbirth” makes it difficult to compare incidences in
the different populations observed and to accurately as-
sess the extent of the problem.
Every year worldwide there are about 2.6 million IUFD
cases at or above 28 gestational weeks, [3] with an inci-
dence ranging from 3.4 per thousand (‰) total births in
high-income countries to 36 in the Sub-Saharan and
Southern Asia regions [12].
Another obstacle to the accurate evaluation of this
phenomenon and the comparison between studies, is the
difficulty to identify the underlying cause, which can ob-
viously be ascribed to one of three factors: maternal, pla-
cental and fetal. These factors very often interact with
one another, leaving space for subjective interpretation
when attempting to identify the actual etiology. Some 81
different classification systems for the causes of fetal
death have been counted in the literature [13].
From the clinical point of view, regardless of the ac-
curacy of the investigations carried out in IUFD cases, in
a quota ranging between 25 and 60% it is impossible to
identify a specific pathological condition, in particular if
the birth weight centile is unknown [14]. In this regard,
the work of J. Gardosi has been crucial: he suggested the
adoption of a classification system, named ReCoDe, that
classifies cases according to the birth weight centile, cor-
rected for ethnicity, to identify true cases of Small for
Gestational Age [15–17]. This allowed growth restriction
to be recognized as a cause of IUFD in the absence of
any other pathology, even if the blood outflow into the
maternal circulation and the post-mortem maceration
processes could lead to an overestimation of SGA
fetuses.
Finally, the cause of death is often confused with the
etiopathogenetic mechanism that determined it. An in-
teresting attempt, aimed at solving this issue, was imple-
mented by Korteweg and colleagues, who proposed a
system, adopted prospectively in the Netherlands and
named “The Tulip Classification”, [18] designed to iden-
tify the cause of IUFD from the pathophysiological
mechanism that triggered the chain of irreversible events
leading to fetal death. According to the Authors, the
adoption of such a classification would allow reducing
the cases of unexplained IUFD, obtaining well-defined
diagnoses as a result of the full sharing of case informa-
tion among professionals called to identify them.
Our study aimed to determine the incidence of IUFD
over an 11-year observational period in the Italian Re-
gion of Friuli Venezia Giulia, and to report on the
causes. The secondary aim was to identify the problems
both in the causes (i.e. avoidable) and in the failure in
their identification, in order to define a shared multidis-
ciplinary diagnostic protocol (obstetric / anatomopatho-
logical / genetic / microbiological) to be applied in the
regional area, based on actual evidence.
Methods
This is a retrospective study that involved all of the
existing eleven maternity centers of the Friuli Venezia
Giulia Region, located in North-East Italy. Friuli Venezia
Giulia has 1.2 million inhabitants, and is divided into
four provinces. Two of the eleven maternities are tertiary
centers, both reaching approximately 1.5 thousand deliv-
eries per year. They are located in Trieste and Udine,
the two main towns, of approximately 200 thousand and
100 thousand inhabitants, respectively. The other nine
maternities are secondary centers, located both in urban
(two in Pordenone, and one in Gorizia and Monfalcone)
and rural areas (Tolmezzo, San Vito al Tagliamento,
Latisana, San Daniele, Palmanova).
We identified all intrauterine fetal deaths (IUFDs) oc-
curred ≥23 gestational weeks, for the years 2005–2015,
by event, date of event and birth center. We were unable
to guarantee the quality of the data recorded prior to
2005. The choice of the 23rd gestational week cut-off
was made based on the reasons mentioned in the Intro-
duction section. IUFDs were identified through the hos-
pital discharge records (SDO: Scheda di Dimissione
Ospedaliera) data system. Available information on the
number of events and the dates were then sent to all
birth centers. The obstetricians designated for the study
were asked to complete an electronic questionnaire re-
covering information from medical records. The ques-
tionnaire was developed by the study coordinator (SA)
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with the support of the epidemiology unit of the coord-
inating center (Clinical Epidemiology and Public Health
Research Unit of the Institute for Maternal and Child
Health – IRCCS Burlo Garofolo, Trieste, Italy), designed
to obtain information on the epidemiological character-
istics of the women whose pregnancies ended with an
IUFD, and to identify specific risk factors attributable to
the IUFD, relating to conditions either preceding con-
ception or occurring during gestation. The classification
adopted was based on similar classifications available in
the literature, [19] and in particular on the NICE Guide-
line 121, [20] modified according to the definition of ob-
stetric pre-post conception risk factors adopted by the
Centre for the management of at-risk pregnancies of the
Institute for Maternal and Child Health – IRCCS Burlo
Garofolo.
Fetal growth restriction (FGR) was reported among
the fetal conditions, and was considered as an anomaly
in growth parameters at ultrasound during gestation. At
delivery, in most cases, fetuses were also classified by
their weight by gestational age, and were classified as
small for gestational age if their weight was below the
10th centile of the normal birth weight distribution.
Each center then gathered and sent back to the coord-
inating center the information for analysis.
Statistical analyses were mainly descriptive. Data are
presented as frequencies and percentages, and medians
with interquartile ranges (IQR). P-values for the signifi-
cance of associations in 2 × 2 tables were the result of
two-tailed Fisher exact tests. For the comparison of con-
tinuous variables between two groups, we carried out
Mann-Whitney rank-sum tests. A p-value< 0.05 was
considered significant. To analyze the time trend in the
number of IUFDs per year, we calculated weighted mov-
ing averages, adding the crude value for the reference
year with the previous and next weighted 0.5, and divid-
ing by 2. The first and last values were calculated adding
the crude value for the reference year with the next, or
previous, respectively, weighted 0.5, and the sum was di-
vided by 1.5. All analyses were carried out with SAS 9.4
(SAS Institute Inc., Cary, USA) and Stata/IC 14.2 (Stata-
Corp LLC, College Station, USA).
Results
For the period 2005–2015, 303 IUFD cases were identi-
fied through the electronic record system. These repre-
sent an incidence of 2.8‰ over the number of live births
in the same time period (n = 108,351 according to the
Microdata Repository of Friuli Venezia Giulia), with a
substantially constant trend in the considered years. This
incidence does not take into account the voluntary ter-
mination of pregnancies for fetal malformations before
the 23rd week of gestation. Fetal malformations among
the IUFDs identified were the consequence of the
woman’s choice not to terminate the pregnancy, or of
missed detection in the prenatal period.
The analysis of the time trend of these 303 IUFDs,
adopting a weighted moving average, shows a downward
trend from 2005 to 2015, with the actual number going
from 38 in 2005 to 19 in 2015 (Fig. 1). The rate de-
creased from 3.1‰ in the period 2005–2008, to 2.8‰ in
2009–2012, to 2.3 ‰ in the period 2013–2015.
Of these 303, however, only 278 medical records could
be identified by the maternity centers and were thus an-
alyzed in our study. The characteristics of the 25 missing
IUFD were almost impossible to analyze, as we could
only count on the date of event and the maternity center
where it occurred. Centers had from 0 to 29% missing
records and, throughout the years, we went from 0 miss-
ing in 2010 and 2013 to 27% in 2006.
The population of women who experienced IUFD was
divided into four age groups and is shown in Fig. 2, to-
gether with a comparison of the same age distribution of
women at delivery (live births).
We did not find significant differences in the distribu-
tion of age of women suffering IUFDs compared to
women with live birth deliveries. About 60% of IUFD
cases occurred in the 30–39 age groups, with a median
age of 33 years (IQR 29–36), if compared to women with
a live-birth delivery (median age 32 years: IQR 28–36;
p = 0.14). The percentage of primigravidae was 59%,
which is line with population of women delivering a
live-born child in the same Region.
Table 1 shows the proportion of women suffering
IUFD compared to women with live-birth deliveries in
Friuli Venezia Giulia region, by ethnic origin. Significant
differences, with higher IUFDs, were registered for
women of African (two-tailed Fisher exact test: p =
0.008) and Latin American origin (p = 0.005).
The median gestational age at IUFD was 34 weeks
(IQR 30–38). Regarding gestational age, the rate of
IUFDs over live births decreases dramatically from
120.4‰ in the 23–24 weeks of gestation group to 0.6‰
and 0.9‰ of the 39–40 and 41–42 weeks of gestation
groups, respectively (Fig. 3 and note to Fig. 3). Despite
this trend, 94 cases (34%) occurred > 36 gestational
weeks.
In 54% of the IUFDs, the fetus was a male, compared
to 51% of live births (p = 0.549).
The percentage of IUFD with birthweight below the
10th centile for the respective sex and gestational week,
according to Italian reference growth curves, [21] was
30% (83 over 278).
Out of the 257 IUFD for which we had data, 242 had
done a 20 weeks ultrasound screening for fetal congeni-
tal malformations. Through this screening, twelve major
malformations were identified, four of which also pre-
sented minor malformations. In addition, three minor
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Fig. 1 Time distribution of cases of intrauterine fetal deaths (IUFDs) (grey line) and corresponding weighted moving average (WMA, in yellow)
Fig. 2 Women who suffered an intrauterine death at ≥23 weeks of gestation, compared to women with live-birth deliveries, by age group:
period 2005–2015
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malformations, compatible with life, were also recorded.
The overall incidence of fetal malformations among
IUFDs was 6%.
In 14 (5%) cases of IUFD, fertilization had been ob-
tained in vitro (IVF), compared to 2% in live-birth deliv-
eries. In four cases (1.4%) the cause of IUFD was
identified as a seroconversion for a TORCH complex
during gestation.
The presence of a nuchal cord was described at birth
in 55 fetuses (20%). Of these, 23 also presented other
pathologies, nine did not but were SGA, while 23 did
neither have other pathologies nor were SGA. The nu-
chal cord was, however, never reported as the cause of
fetal death.
In the medical records, 162 women had at least one
high-risk condition reported (58%) (Tables 2 and 3). In
this group, 36% IUFDs were under the 10th centiles of
weight (small for gestational age: SGA) (Table 3). If we
consider SGA as an additional potential cause of IUFD,
even in the absence of other reported conditions, this
leaves 79 cases of IUFD (28%) with no attributed risk
factor.
We then evaluated, based on the ultrasound charts, in
how many cases a deviation of the biometric parameters
of fetal growth was found, indicating a restriction. Intra-
uterine fetal growth restriction was reported in 43 cases
(16%), of which 30 (70%) were considered SGA at birth,
as defined by the center.
There were 36 cases (13%) of placental abruption. Of
these, eight (22%) occurred during labor and 12 (33%)
showed an association with a maternal hypertensive/pre-
eclamptic disease.
The assessment of the medical records allowed the
identification of 32 cases (11%) presenting clinical signs
of chorioamnionitis in pregnancy. Given the retrospect-
ive nature of the study, we were unfortunately unable to
recover information on the full diagnostic path and the
simultaneous presence of maternal or fetal vascular mal-
perfusion. In Fig. 4, these cases are stratified by gesta-
tional week at IUFD, and we notice that cases are
Table 1 Women who suffered an intrauterine death at ≥23 weeks of gestation, compared to women with live-birth deliveries, by
ethnic origin: period 2005–2015








Women with Intrauterine Death 241 (87%) 24 (9%) 5 (2%) 8 (3%) 278 (100%)
Women with live-birth deliveries 93,770 (91%) 5036 (5%) 3015 (3%) 969 (1%) 102790a (100%)
p-value 0.011 0.008 0.370 0.005
a Total women were 110,415, but 7625 (6.9%) had missing data on origin
p-values are calculated for each category against all other categories together; two-tailed Fisher exact test
Fig. 3 Women who suffered an intrauterine death at ≥23 weeks of gestation, compared to women with live-birth deliveries, by gestational age at
event: period 2005–2015Note to Fig. 3. The rate of IUFD over live births, by gestational age, is the following: Overall: 2.6‰; 23–24 weeks: 120.4‰;
25–26: 125.0‰; 27–28 weeks: 88.6‰; 29–30 weeks: 66.8‰; 31–32 weeks: 35.9‰; 33–34 weeks: 17.8‰; 35–36 weeks: 7.9‰; 37–38 weeks: 1.7‰;
39–40 weeks: 0.6‰; 41–42 weeks: 0.9‰.
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distributed quite evenly throughout the gestational ages
considered.
The amniotic fluid assessment in the last performed
ultrasound showed the presence of oligohydramnios in
23 cases (8%), with 12 of these (52%) presenting SGA fe-
tuses at delivery. Ten cases (4%) polyhydramnios were
also identified, but we did not find associations with dia-
betes, isoimmunizations, nor other conditions.
Finally, we identified 32 cases (11%) which occurred
during labor, which had started spontaneously. These
are shown, stratified by gestational age, in Table 4.
In the diagnostic evaluation of the dead newborn, a
photographic documentation was available only in 4% of
the cases, and the autoptic examination of the fetus had
been performed only in 21% of the cases, even if the
histological examination of the placenta, carried out by
pathologists often not experts of this field, had been car-
ried out in 95% of cases.
For the 258 cases for which we had information both
on conditions associated to IUFD and SGA, there was
no difference in the percentage of those in which neither
of these conditions was present by comparing fetuses
Table 2 Conditions that could have been associated with the intrauterine death, as reported in the medical records of the women
Class of Pathology Pathology N % over 278 IUFDs
Fetus Congenital anomalies incompatible with life 7 2.5
Chronic infections (i.e. TORCH Syndrome) 4 1.4
Acute infections 21 7.6
Non-immune fetal hydrops 5 1.8
Isoimmunization 1 0.4
Feto-maternal transfusion 0 0.0
Feto-fetal transfusion syndrome 1 0.4
Fetal Growth Restriction 43 15.5
Placenta Placental abruption 36 12.9
Amniotic Fluid Chorioamnionitis 32 11.5
Uterus Uterine Rupture 2 0.7
Maternal o Mother Diabetes 29 10.4
Essential hypertension 14 5.0
Pre-eclampsia 27 9.7
Lupus/Antiphospholipid antibody syndrome 4 1.4
Cholestasis 5 1.8
Alcohol abuse 1 0.4
Smoking Abuse (> 5 cigarettes/day) 6 2.2
Drug addiction 1 0.4
During delivery Asphyxia 9 3.2
Total conditions reported 248
The 248 conditions were reported for 162 IUFD cases. In addition, at least another 30 fetuses with no other condition were small for gestational age (SGA), while
we did not have information on SGA on other 20 cases. The remaining 79 cases did not present any condition and were not SGA
Table 3 Women with reported conditions that could have been associated with the intrauterine death, and evaluation of growth of
the fetus at IUFD
No Small for Gestational Age Small for Gestational Age Total p-value
Conditions
- No condition 79 (72%) 30 (28%) 109 (100%)
- At least one condition 96 (64%) 53 (36%) 149 (100%) 0.180*
Hypertension in pregnancy
- No hypertension in pregnancy 156 (70%) 66 (30%) 223 (100%)
- Hypertension in pregnancy 19 (53%) 17 (47%) 36 (100%) 0.053*
Total 175 (68%) 83 (32%) 258 (100%)**
* Two-tailed Fisher exact test
** Missing data due to lack of data on sex (recorded as ambiguous) or weight. Of the 20 missing in this table, 13 presented at least one condition
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that received an autopsy (17/54, 31%) to those that did
not (62/204, 30%; p = 0.870).
Discussion
This study offers several elements for the discussion of
unresolved issues related to IUFD cases, which make it
difficult, among other things, to assess the phenomenon
in the various areas observed, limiting interventions,
both on a clinical and health management basis, aimed
at reducing its incidence to the minimum.
Our decision to focus on IUFD cases with a gestational
age ≥ 23 weeks, regardless of birth weight, depended on
the practice of most Italian obstetricians to allow the
voluntary termination of pregnancy to be completed up
to the 22nd completed week + 6 days, considering the
higher probability of having neonatal survivals after this
limit, as previously explained. In this way the population
we studied was homogeneous, having excluded the ma-
jority of pregnancies with malformed fetuses, which in
Italy generally undergo a voluntary termination of preg-
nancy. This also explains the low percentage of IUFDs
with malformations detected in this study.
The recorded incidence of IUFD – 2.8‰ live births,
and decreasing from 3.1 during the period 2005–2008 to
2.3 in 2013–2015 – is in line with that reported by other
studies, carried out in high-income countries. It must be
emphasized, however, that in our case, most pregnancies
with fetal malformations had been excluded for the rea-
sons explained above [21]. Our reported figure is cer-
tainly lower than the 6.2‰ figure reported in the USA
in 2004, considering IUFDs occurring from the 20th
week of gestation, [22] the 7.1‰ registered in Australia
following the WHO criteria, [23] and higher than the
one reported in the UK in 2015, of 1.1‰ [24].
With regard to maternal age, the highest IUFD rate,
over live birth deliveries, was in the > 40 age group
(4.0‰), followed by the < 20 age group (3.1‰). The 20–
29 and 30–39 had respectively 2.4‰ and 2.5‰. 60% of
Fig. 4 Frequencies and percentages of chorioamnionitis among intrauterine deaths (IUFDs), by gestational week at IUFD
Table 4 Frequencies and percentages of intrauterine deaths
(IUFDs) occurred during labor, by gestational week at IUFD
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all IUFD cases fell into the 30–39 years age group, which
corresponds to the percentage of women in the same
age group delivering in our Region. In similar studies,
the distribution of IUFDs cases in relation to live birth
deliveries was quite similar [25].
The distribution of IUFD cases by gestational age is
comparable to that of the general population of our Re-
gion, [26] in contrast with other studies, that observed a
progressive decrease in the prevalence of IUFDs as ges-
tational weeks increase [27].
In analogy with what reported by other authors [6, 28–
30] a higher risk of IUFD prevalence emerged in women of
African origin (p < 0.003) compared to the Caucasians. A
greater risk was also observed in women of Latin-American
origin (p < 0.004). An open question is whether this is due
to characteristics of greater risk of death in utero in these
ethnic groups, or to the difficulty of taking full advantage of
the socio-health conditions of the country in which they
are immigrants, welfare conditions, which could have lim-
ited the phenomenon. In some studies, the greater preva-
lence of IUFDs observed in Black women was associated
with a state of pregnancy-induced hypertension [28, 29].
Given the small number of women with African origin and
the small number of women with hypertension, we could
not find a significant association between origin and hyper-
tension (p-value = 0.12).
Even though we reported the percentage of nuchal
chord in our population (20%), it is important to note
that a) this percentage is lower than that found in our
records of deliveries, which is around 30%, and b) nuchal
chord was never identified as the cause of fetal death.
It is known that fetal growth restriction is a risk factor
for fetal death [15–17]. In our study, the prevalence of
SGA births was 30%, higher than that normally observed
in the general population, which is around 10% by defin-
ition. The higher percentage of fetal growth restriction
in IUFDs finds solid confirmation in similar studies
[9, 10, 17, 31].
The identification of pre-gestational and gestational
diseases, including obstetric conditions, as well as those
of fetal relevance, also occurring in association, showed
that in a proportion of 42% of cases (108/259) there was
no pathological, maternal/placental/fetal condition that
could justify the adverse outcome verified. By including
the condition of SGA as risk factor, this percentage de-
creased to 30% of the cases (78/259), confirming on the
role played by the restriction of fetal growth in the de-
terminism of the IUFD.
In the group of pregnant women in whom a pathology
was present, the prevalence of SGA was 36% (53/149).
This indicates that a woman having at least a pre-
pregnancy or pregnancy disease is at higher risk of hav-
ing a fetal growth restriction, which is certainly a factor
to be always considered for its association with IUFD.
There is no doubt that there may also be unknown
pathological factors, in the biochemical, genetic or im-
munological field, which do not allow for a complete
identification of the pathologies leading to IUFD in all
cases. Towards these factors we need focus our attention
and, above all, our post-natal investigations. In our opin-
ion, however, this gap may also depend on a non-
exhaustive and complete diagnostic procedure, applied
in these of IUFD after birth.
Consideration must be made on the high frequency of
cases in which a condition of chorioamnionitis (11%)
had occurred, a share that is certainly higher than the
values reported in the literature for this pathology and
that is usually estimated in the range of 1–4% [32, 33].
Chorioamnionitis was defined by the association of clin-
ical signs of maternal inflammation with fetal tachycar-
dia. However, the retrospective nature of our study did
not always allow us to confirm the reported diagnosis.
We need to admit that the reported diagnostic path-
way implemented on the dead newborn was inadequate.
Genetic diagnoses were only available during gestation
in 16% of cases, not significantly increased after fetal ex-
pulsion. A picture of the newborn was only done in 4.4%
of cases, and autopsy on the fetus was carried out only
in 11% of cases. The application of specific and shared
anatomopathological classification systems, implemented
both on the fetus and on the placenta, by experienced
IUFD specialists, could contribute to the reduction of
cases in which no cause could be identified. It is known
that the proportion of unexplained IUFDs is reduced in
those situations where shared and systematic diagnostic
criteria and procedures are applied [34]. We believe this
aspect is also important to give a just and dutiful answer
to the couple that suffered this dramatic event, which in
our population occurred after 30 weeks of gestation in
72% of the cases, when the chances of newborn survival
increase significantly with good intensive care, and after
36 weeks in 34% of cases, meaning at term.
Some 88% of IUFD cases recorded in this study oc-
curred in the antepartum period and this figure is in line
with what was reported by other works carried out in
high-income countries, where 90% of deaths in utero
occur precisely in this period and are often associated
with preventable risk factors, such as obesity, smoking,
failure to identify pregnancies at risk [6, 27–35]. There-
fore, being able to understand the cause of death in
utero would allow addressing the available resources
more appropriately to combat the etiological factors on
which it is possible to implement concrete prevention.
The last aspect deserving attention, and which we con-
sider worthy of further evaluation, concerns the 11%
share of cases in which fetal death occurred during labor
(Table 4). The question to be answered in this regard is
whether adequate and correct obstetric management
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could reduce this burden to the minimum, by imple-
menting quality improvement programs, already realized
elsewhere [25].
Conclusion
The percentage of IUFD cases in which no possible
cause could be identified is still quite high. Only the
adoption of evidence-based diagnostic protocols, with
integrated immunologic, genetic and pathologic exami-
nations, can help reduce this diagnostic gap, contribut-
ing to the prevention of future IUFDs.
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